It is now established that the subdasses of mast cells (MC) that reside in mucosal and serosal environments can be distinguished from one another in terms of their expression of specific secretory granule-localized proteases and proteoglycans. Further, the hematopoietic-and connective tissue-derived cytokines that regulate expression of the genes that encode these constituents of the granule can now be identified using recently developed gene-specific probes and recombinant cytokines. When bone marrow-derived MC (BMMC) were developed with recombinant interleukin 3 (rlL-3) and maintained with this cytokine in the absence or presence of recombinant c-kit ligand (rKL), they remained saffanin-, produced almost no 3sS-labeled heparin proteoglycans, and contained greater levels of mouse MC protease (MMCP) -5 mKNA and mast cell carboxypeptidase A (MC-CPA) mKNA than MMCP-6 mKNA. They did not contain MMCP-4 or -2 mKNA, genes expressed late in the differentiation of progenitor cells into serosal and mucosal MCs, respectively. In contrast, BMMC developed with rKL alone or by sequential culture in medium containing rlL-3 followed by rKL expressed high levels of MMCP-4 and -6 mRNA, as well as the transcripts that encode MMCP-5 and MC-CPA. Although rKL-developed BMMC were saffanin + and produced substantial amounts of 3sS-labeled heparin proteoglycans, they contained only minimal amounts of histamine and MC-CPA enzymatic activity relative to serosal MC. These are the first studies to characterize the transcriptional granule phenotype of a population of BMMC derived using any recombinant eytokine, to demonstrate a dissociation between histochemical staining and granule maturation, and to demonstrate antagonistic regulation of late expressed protease genes by a eytokine.
Summary
It is now established that the subdasses of mast cells (MC) that reside in mucosal and serosal environments can be distinguished from one another in terms of their expression of specific secretory granule-localized proteases and proteoglycans. Further, the hematopoietic-and connective tissue-derived cytokines that regulate expression of the genes that encode these constituents of the granule can now be identified using recently developed gene-specific probes and recombinant cytokines. When bone marrow-derived MC (BMMC) were developed with recombinant interleukin 3 (rlL-3) and maintained with this cytokine in the absence or presence of recombinant c-kit ligand (rKL), they remained saffanin-, produced almost no 3sS-labeled heparin proteoglycans, and contained greater levels of mouse MC protease (MMCP) -5 mKNA and mast cell carboxypeptidase A (MC-CPA) mKNA than MMCP-6 mKNA. They did not contain MMCP-4 or -2 mKNA, genes expressed late in the differentiation of progenitor cells into serosal and mucosal MCs, respectively. In contrast, BMMC developed with rKL alone or by sequential culture in medium containing rlL-3 followed by rKL expressed high levels of MMCP-4 and -6 mRNA, as well as the transcripts that encode MMCP-5 and MC-CPA. Although rKL-developed BMMC were saffanin + and produced substantial amounts of 3sS-labeled heparin proteoglycans, they contained only minimal amounts of histamine and MC-CPA enzymatic activity relative to serosal MC. These are the first studies to characterize the transcriptional granule phenotype of a population of BMMC derived using any recombinant eytokine, to demonstrate a dissociation between histochemical staining and granule maturation, and to demonstrate antagonistic regulation of late expressed protease genes by a eytokine.
M
ast cells (MC) 1 that reside in different tissue sites are heterogeneous in terms of their secretory granule proteoglycans and proteases. Safranin + granules of mouse serosal MC, considered to represent the connective tissue MC subclass, contain abundant amounts of heparin proteoglycans, MC carboxypeptidase A (MC-CPA), mouse MC protease (MMCP) -3, -4, -5, -6, but no MMCP-1 or -2 (1-8). In contrast, the safranin-mucosal MC subclass found in the intestines of helminth-infected mice express MMCP-1 (9) and -2 (5), but little MC-CPA (4), and no MMCP-5 (7) or -6 (8) .
The factors that regulate the diversity of MC proteases are unknown, but tissue-related MC heterogeneity may be a consequence of the particular panel of cytokines provided in varied t Abbreviations used in this paper: BMMC, bone marrow-derived MC; KL, c-kit ligand; MC, mast cell; MC-CPA, MC carboxypeptidase A; MMCP, mouse MC protease; SG-PG, secretory granule proteoglycan peptide core; and TSG, 0.1 M Tr/s-HCI, 0,1 M sodium sulfate, and 4 M GnHC1.
microenvironments (10) (11) (12) (13) (14) . Mouse bone marrow cells cultured in medium containing IL-3 differentiate into morphologically immature MC that express the high affinity IgE receptor FceKI (15) (16) (17) (18) (19) (20) (21) . When this receptor is crosslinked with antigen, lipid mediators are generated and released (22) (23) (24) , cytokines are transcribed and translated (25) (26) (27) (28) , and preformed mediators are released from the secretory granules (2, 22, 29, 30) . These in vitro differentiated mouse bone marrow-derived MC (BMMC) are alcian blue+/safraninwhen stained, and they preferentially synthesize chondroitin sulfate E proteoglycans, rather than the heparin proteoglycans that predominate in mouse serosal MC (1). BMMC are poorly granulated (31, 32) and contain low amounts of histamine (16, 20) , secretory granule serine proteases (29) , and MC-CPA (2). The granule proteases expressed by BMMC derived using rlL-3 (termed BMMCIL-3) have not been determined, but BMMC differentiated in the presence of WEHI-3 cell-conditioned medium as a source of IL-3 (termed BMMCw) ex-press the transcripts that encode MC-CPA (4), MMCP-5 (7), and -6 (8), but not MMCP-2 (5) or -4 (6). The latter two are late expressed protease genes of mucosal and serosal MC, respectively.
During 4 wk of coculture of BMMC with mouse 3T3 fibroblasts in the presence of WEHI-3 cell-conditioned medium, the resulting cells, termed BMMCw/F, become safranin + and preferentially synthesize heparin proteoglycans rather then chondroitin sulfate proteoglycans (12) . Their secretory granules also become more electron dense (32) , possessing amounts of histamine (12, 33) and MC-CPA activity (2, 33) comparable to in vivo differentiated serosal MC. Both WBB6F1-W/W v mice which contain an altered (34) plasma membrane-localized tyrosine kinase designated c-kit (35, 36) , and WCB6Ft-S1/S1 a, which do not produce a membrane form of the fibroblast-derived cytokine designated c-kit ligand (KL, also known as stem cell factor or MC growth factor [37] [38] [39] [40] [41] [42] [43] [44] ) are MC defident (45, 46) . Recombinant KL functions as a pluripotent cytokine (47) (48) (49) that elicits proliferation of mouse MC in vitro (41, 48) . It also induces the appearance of safranin + MC when injected subcutaneously into SI/S1 d mice (44) , but it is not known which granule proteases are expressed by MC exposed to rKL.
In this study, we have examined the transcriptional phenotypes of mouse MC that have been derived in vitro directly from bone marrow cells using either rKL or rlL-3, and sequentially using BMMCw exposed to rKL, rlL-3, or both together. We show that even though rlL-3 and rKL both induce the proliferation and differentiation of hematopoietic progenitor cells into MC, the resulting MC can be distinguished by their expression of certain constituents of their secretory granules. In contrast to rlL-3, rKL not only induces the expression of heparin proteoglycans, but also the transcription of a late expressed gene that encodes one of the novel secretory granule proteases (MMCP-4) that is preferentially expressed by mouse serosal MC. rib3 has an antagonistic effect on these rKIAnduced phenotypic changes. These findings demonstrate cytokine regulation of transcription of secretory granule neutral protease genes, and specifically iUustrate the sequential and competitive interaction of IL-3 and KL in determining the eventual protease phenotype of BMMC.
Materials and Methods
Culture of MC. Mouse BMMC were obtained by culturing bone marrow cells from the femurs and tibias of 6-16-wk-old BALB/c mice (Charles River Breeding Laboratories, Inc., Wilmington, MA) for 1-3 wk in enriched medium (RPMI 1640 containing 100 U/ml penicillin, 100/~g/ml streptomycin, 10/zg/ml gentamicin, 2 mM t-glutamine, 0.1 mM nonessential amino acids, 50 #M 2-ME, and 10% FCS [Gibco Laboratories, Grand Island, NY]) containing either 200 ng/ml rKL (Immunex Corporation) or 40 U/ml rib3 (Genzyme Corp., Boston, MA). Alternatively, mouse bone marrow cells were cultured for 3 wk in 50% enriched medium and 50% WEHI-3 cell (line TIB-68; American Type Culture Collection, Rockville, MD) -conditioned medium (20) . In some instances, these latter BMMCw were washed twice with 100% enriched medium, and were then cultured for 1-2 wk at an initial density of 1-3 x 105 cells/ml in enriched medium supplemented with 20-100 U/ml rlL-3, 200 ng/ml rKL, or a combination of both cytokines to study their action on an elicited immature MC population, rKL and rIL-3 were both expressed in yeast. Previous reports had shown that 20 U/ml of IL-3 purified from WEHI-3 cell-conditioned medium was sufficient to induce the proliferation and differentiation of BMMC (20) , and that a maximum proliferation of MC-9 ceils occurred when this transformed MC line was exposed to 100 ng/ml of rKL (48) . Every 7 d, the nonadherent cells in all of the cultures were transferred into fresh culture medium containing the appropriate cytokine and adjusted to a density of 1-3 x 105 ceils/ml. Cytocentrlfuge preparations of the cultured MC were stained with toluidine or with alcian blue followed by safranin (50, 51) .
RNA Blot Analysis. Total cellular RNA was isolated by the method of Chomczynski and Sacchi (52) , and was quantified by measurement of its OD at 260 nm. Approximately equal amounts of total RNA were applied to individual lanes of 1.3% formaldehydeagarose gels, and electrophoresis was carried out for 17-24 h. The separated RNAs were transferred to nylon membranes (Cuno Inc., Meriden, CT) (53) , and the resulting blots were probed with radiolabeled cDNAs that encode either mouse actin (54), MC-CPA (4), MMCP-2 (5), -4 (6), -5 (7), -6 (8), mouse secretory granule proteoglycan peptide core (SG-PG) (55) , or the c~ chain of FceRI (28, 56) . All hybridizations were performed with ot-[32p]dCTP (,,o3,000 Ci/mmol; DuPont/New England Nuclear, Boston, MA) random-primed (Boehringer Mannheim, Indianapolis, IN) cDNA probes at 43~ for 24 h in 50% formamide, 0.75 M NaC|, 75 mM sodium citrate, 0.1% SDS, 5 mM EDTA, 50 mM sodium phosphate, 2 x Denhardt's buffer, and 100 #g/m1 denatured, singlestranded herring sperm DNA (Sigma Chemical Co., St. Louis, MO). The RNA blots were washed under conditions of high stringency (55~ 30 mM NaC1, 3 mM sodium citrate, 0.1% SDS, 1 mM EDTA, and 10 mM sodium phosphate, pH 7.0), and autoradiography was performed with Kodak XAR-5 film, generally for 48 h. The ~2P-labeled probe was removed from each blot by a 1-h incubation at 65~ in 0.2 mM ~, 0.5% pyrophosphate, 0.1x Denhardt's buffer, 5 mM Tn's-HCI, pH 8.0. The same blot was then assessed for the presence of other transcripts. The presence of MMCP-4 mRNA in rKL-treated cultures was confirmed using a RNase protection assay kit from Ambion, Inc. (Austin, TX).
Proteoglycan, Histaminr and MC-CPA Analyses. BMMCw were cultured for 1 or 2 wk in enriched medium supplemented with rIL-3, rKL, or both cytokines, and then were radiolabeled for 3.5 h at 37~ at a density of 5 x 105 cells/ml in fresh enriched medium containing the appropriate cytokine and 50 #Ci/ml of [~SS]sulfate (10 Ci/mmol; DuPont). The supernatants were removed, analyzed for the presence of ~sS-labeled macromolecules (1), and then discarded. The pelleted 3sS-labeled MC were lysed by suspending the ceils in 150 #1 of 1% Zwittergent 3-12 (Calbiochem-Behring Corp., San Diego, CA) containing protease inhibitors (57) for '~30 s at room temperature, and then in 1,350 #1 of TSG buffer (0.1 M Tris-HC1, 0.1 M sodium sulfate, 4 M GnHC1, pH 7.0). After cell sonication, 200/~g heparin (Sigma Chemical Co.) and 200/~g chondroitin sulfate C (ICN Biochemicals, Lisle, IL) were added as nonradiolabeled glycosaminoglycan carriers to each supernatant and cell lysate. To determine the incorporation of [3SS]sulfate into proteoglycan, a 5% portion of each sample was chromatographed on separate Sephadex G-25/PD-10 (Pharmacia Fine Chemicals, Piscataway, NJ) gel filtration columns that had been equilibrated in TSG buffer. Solid CsC1 was added to the remainder of the cell extract samples to achieve final densities of 1.4 g/ml, and these samples were centrifuged at 100,000 g for >42 h at 20~ (58, 59) . After ultracentrifugation, each density gradient was divided into two approximately equal fractions. The 3sS-labeled macromolecules present in samples of both the low and high density fractions were quantified by Sephadex G-25 chromatography. The high density fractions were then dialyzed against distilled water for 1 h at 4~ against 0.5 M sodium acetate for "o7 h, and finally against 0.1 M ammonium bicarbonate for 48 h. After lyophilization, the samples were resuspended in 1 ml distilled water and stored at -200C. To determine the hydrodynamic sizes of the 3sS-labeled macromolecules, portions of the purified 3sS-labeled macromolecules were made 4 M in GnHC1, and were applied to a 1 x 85-cm Sepharose CI~4B (Pharmacia Fine Chemicals) column that had been equilibrated at room temperature under dissociative conditions with TSG buffer. The radioactivity present in each collected 0.5-ml fraction was quantified by B-scintillation counting.
To quantitate the amount of 3SS-labeled heparin and/or heparan sulfate glycosaminoglycans in the cell lysates, 25-#1 samples of the density gradient-purified 3sS-labeled macromolecules were incubated for I h at 0~ with 75/xl of a fresh preparation of 0.25 N nitrous acid, pH 1.5 (60) . The reactions were terminated by the addition of 150/A of 1 M sodium carbonate followed by 200/A of TSG buffer. The amount of 3sS-labeled chondroitin sulfate in each preparation of 3sS-labeled proteoglycans was determined by assessing the susceptibility of each preparation to digestion by chondroitinase ABC (ICN Biochemicals) (61, 62) . The nitrous acidtreated, chondroitinase ABC-treated, and untreated control samples were analyzed by Sephadex G-25 chromatography.
Samples of the cell lysates were also analyzed for their histamine content with a radioimmunoassay kit (AMAC, Westbrook, ME) (63), and for their MC-CPA activities with a HPLC assay, which measures the generation of phenylalanine from hippuryl-t-phenylalanine (2). 1 mU of MC-CPA activity is defined as the amount of enzyme needed to produce 1 nmole of phenylalanine/min from hippuryl-t-phenylalanine.
Results

Histochem~al and ~a~c@aona! Phenotype of Mo~e MC Derived Directly by Culturing Mouse Bone Marrow Cells in Medium
Containing either rlL3 or rKL. As assessed by toluidine blue staining, >99% of the cells derived by culturing bone marrow ceils in the presence of rIL-3 (BMMCIL-3) (Fig. 1 a) or WEHI-3 cell-conditioned medium (BMMCw) (data not shown) for 3 wk were MC. When stained with alcian blue followed by saffanin, the granules of all of the MC in these two culture systems were alcian blue+Aafranin - (Fig. 1 c) . In contrast, <30% of the cells in the rKbtreated bone marrow cultures were MC (BMMC~) by vital staining of their granules (Fig. 1 b) , but almost all of these BMMCKL had granules that were alcian blue+/safranin + (Fig. 1 d) .
RNA blot analyses indicated that starting mouse bone marrow cells contained abundant amounts of SG-PG mRNA, but no detectable levels of those transcripts that encode MC-CPA, MMCP-2, -4, -5, -6, or FceRI,~ (Fig. 2) . During culture of bone marrow cells for 1-3 wk in the presence of 200 ng/ml rKL, there was a progressive increase in the mRNA levels that encode MC-CPA, MMCP-4, -5, -6, and FceRI~ in the nonadherent population of cells. The MMCP-2 transcript that is preferentially expressed by mucosal MC (5) was not detected in any of the cultures. No MMCIX4 or -2 mRNA was present in BMMCIL-3 or BMMCw derived by culturing bone marrow cells for 3 wk in enriched medium containing 40 U/ml rlL-3, or 50% WEHI-3 cell-conditioned medium respectively, (Fig. 2) . Nevertheless, these two populations of MC contained abundant amounts of those mRNAs that encode MC-CPA, MMCP-5, SG-PG, and FceRI~. Although the MMCP-6 gene was transcribed in BMMCIr-3, the amount of this transcript per MC was less than in BMMCKt or BMMCw.
Histochemical and Transc@tional Pkenotype of BMMCw Subsequently Exposed to rlL3, rKL, or both Cytokines. When
BMMCw were exposed for 1 wk to 20-40 U/ml rIL-3, 200 ng/ml rKL, or these same concentrations of both cytokines together, the number of ceils in the cultures increased 1.3 _+ 0.3, 6.0 _+ 4.3, and 10.5 _+ 1.9-fold (mean + SD, n = 5), respectively. All of the cells in the 1-and 2-wk cultures remained toluidine blue + (data not shown). All of the granules in the 1-(data not shown) and 2-wk (Fig. 1 e) BMMCw/m-3 (BMMCw cultured for 1 and 2 wk in enriched medium containing 20 U/ml [n = 2], 40 U/m1 In = 1], or 100 U/ml [n = 3] rlL-3) remained safranin-when stained. Only a few of the cells in the 1-wk BMMCw/~ cultures (BMMCw cultured for 1 and 2 wk in enriched medium containing 200 ng/ml rKL [n = 6]) contained safranin + granules (data not shown). However, most of the 2-wk BMMCw/gL had at least one safranin + granule, and in many instances, 100% of the granules in individual MC were safranin § (Fig. l f) . No safranin + MC were detected in the 1-wk (data not shown) or 2-wk (Fig. 1 g) cultures of BMMCw/ir-3,gt (BMMCw cultured for 1 and 2 wk in enriched medium containing a combination of 20-100 U/ml rlL-3 and 200 ng/ml rKL [n --6]).
Analysis of the transcription phenotype of these different populations revealed that BMMCw/IL-3 ( Fig. 3) were similar to BMMCw (Fig. 2) in that they continued to express those transcripts that encode MC-CPA, MMCP-5 and -6, SG-PG, and FceRI,~. All but MMCP-6 mRNA remained abundant and apparently unchanged. In contrast, BMMCw/IcL expressed detectable levels of MMCP-4 mRNA at 1 wk, and high levels at 2 wk, in addition to those transcripts that encode MC-CPA, MMCP-5 and -6, SG-PG, and FceRI,~ (Fig.  3) . However, there was no expression of the MMCP-4 gene in BMMCw/IL-3,~, and the amount of MMCP-6 mRNA was also reduced (Fig. 3) . No MMCP-2 mRNA was detected in any of these populations of BMMC.
Proteoglycan, Histamine, and MC-CPA Analyses. BMMCw were exposed to rib3, rKL, or both cytokines for 1 wk (n = 3) or for 2 wk (n = 2), and were then radiolabeled with [3SS]sulfate for 3.5 h. In each instance, >98% of the 3sS-labeled macromolecules produced by the different populations of MC remained cell associated, as determined by Sephadex G-25 chromatography. After density-gradient centrifugation of the high salt/detergent extracts of the individual cell pellets, >84% of the radiolabeled macromolecules were recovered in the bottom fraction, which is consistent with the preferential incorporation of this radioisotope into granuleassociated proteoglycans. Although the hydrodynamic sizes of the 3SS-labeled proteoglycans produced by BMMCw/IL-3, BMMCw/KL, and BMMCw/IL-3,~ did not differ (Fig. 4) , the types of 3sS-labeled glycosaminoglycans bound to these peptide cores differed considerably. When analyzed for their susceptibility to nitrous acid, 9 + 4, 56 +_ 2, and 2 +_ 2% (mean + 50% range, n --2) of the purified 3sS-labeled proteoglycans produced by 2-wk BMMCw/Ir-3, BMMCw/~, and BMMCw/IL-3,ro., respectively, contained heparin-like glycosaminoglycans (Table 1) (c and d) . Because the cell population is not pure in b, arrows indicate the BMMC~. BMMCw of >99% purity were cultured for 2 wk more in the presence of 20 U/ml rIL-3 (e), 200 ng/ml rKL (f), or both cytokines (g), and then were stained with alcian blue followed by safranin. than 1 wk, and was associated with the histochemical detection of saffanin + granules. 1-wk BMMCw/IL-3, BMMCw/KL, and BMMCw/IL-3,r~ contained 180 + 18, 570 + 240, and 520 + 360-ng histamine (mean + SD/106 cells, n = 3), respectively, and 1.5 _+ 0.3, 2.5 _ 0.8, and 0.5 + 0.3 mU MC-CPA enzymatic activity, respectively. When cultured for 2 wk in enriched medium containing the same respective combinations of cytokines, their respective histamine contents were 80 _+ 80, 600 _+ 280, and 110 + 60 ng (mean _+ SD/106 cells, n = 3), and their respective MC-CPA activities were 2.7 + 2.4, 6.8 _+ 2.8, and 0.6 _. + 0.5 mU (Table 1) .
Discussion
This study is the first to delineate the transcription phenotypes of two populations of MC derived by culturing bone marrow hematopoietic progenitor cells in the presence of different recombinant cytokines. By comparing the transcription phenotype of the cells derived with either mouse rlL-3 or rKL, we have identified early and late expressed genes that encode the various constituents of the MC's secretory granule. Further, whereas the sequential action of rlL-3 followed by rKL results in the induction of the full complement of early and late expressed protease genes of serosal MC, exposure of BMMC to both cytokines simultaneously allows rlLo3 to prevail, thereby preventing the changes in both the proteoglycan and neutral protease phenotypes that occur in cells cultured with rKL alone.
Although rlL-3 and rKL are both capable of inducing proliferation and differentiation of bone marrow progenitor cells into MC, the resulting BMMCxL-3 and BMMCI(L differed in their histochemistry and in their proportion of the total cells present in the culture. <30% of the cells in cultures of mouse bone marrow cells exposed to rKL for 3 wk were toluidine blue +/alcian blue + Aafranin + MC (Fig.  1) . BMMCKL contained high levels of mRNAs that encode MC-CPA, MMCP-4, -5, -6, and FceRI~, but not MMCP~ (Fig. 2) . This transcriptional phenotype is indistinguishable from that of in vivo differentiated mouse serosal MC, the prototype of the connective tissue MC subclass (Table 2) . RNA blot analyses of the starting mouse bone marrow cells, and the 1-, 2-and 3-wk BMMCr, L revealed that the SG-PG gene was efficiently transcribed in the starting cells, and that the level of this transcript increased in the subsequent weeks of the culture (Fig. 2) . In BMMC~, the SG-PG gene was expressed before any of the protease genes, most likely so that these enzymes could be efficiently packaged in the secretory granules (2, 30). MC-CPA, MMCpo5 and -6 were expressed next, followed by MMCP-4. All of the BMMC derived by culturing bone marrow cells in the presence of either rlL-3 ( Fig. 1) or WEHI-3 cellconditioned medium were toluidine blue +/alcian blue + / safranin-MC. BMMCIL-3 and BMMCw contained high levels of those mRNAs that encode MC-CPA, MMCP-5, and FceRI~, but lacked MMCP4 mRNA, as well as MMCIX2 mRNA (Fig. 2) . The MMCP-6 gene was expressed in BMMCzt-3, but the amount of this transcript was less than in BMMCw or BMMC~. Although rlL-3 and WEHI-3 cell-conditioned media are more effective than rKL in their ability to induce a virtually pure population of BMMC, only rKL elicits the transcript, MMCP-4. MMCP-4 is a lateexpressed gene observed only when progenitor cells differentiate into serosal MC (6) .
As BMMC are the only cells identified in the cultures of bone marrow cells that have been exposed for 3 wk to either rlI:3 or WEHI-3 cell-conditioned medium, it was possible to directly assess the effects of rKL and rlL-3 on the expression of MMCP-4 and other phenotypic markers in an immature population of MC. BMMCw cultured for 2 wk in medium containing rlL-3 remained saffanin- (Fig. 1 ) and continued to produce predominately 35S-labeled chondroitin sulfate proteoglycans (Table 1 ) and secretory granule protease mRNAs similar to the starting population of MC except for a reduction in MMCP-6 mRNA (Figs. 2 and 3) . BMMCw cultured in the presence of rKL became saffanin + and produced more 3sS-labeled heparin proteoglycans than 3sS-labeled chondroitin sulfate proteoglycans (Table 1) , as previously observed for BMMC derived with Con A-stimulated splenocyte-conditioned medium and then cultured in the presence of rat rKL (64) . The current focus on transcripts that encode secretory granule proteases revealed that mouse rKL induced expression of abundant levels of MMCP-4 mRNA, in addition to those transcripts that encode MC-CPA, MMCP-5 and -6, SG-PG, and FceRI~ (Fig. 3) . In contrast, MMCP-2, a late-appearing phenotypic marker of mucosal MC (5) ( Table  2) , was not detected in BMMC~ (Fig. 2) or in BMMCw/gL (Fig. 3) . Thus, during the differentiation of mucosal MC in the intestines of helminth-infected mice, there must be other factors that suppress transcription of MMCP-5 and -6 and elicit transcription of MMCP-2. Stimulation of BMMCIL.3 with rlL-10 elicits the late expressed gene MMCP-2 (65).
KL is produced by fibroblasts (37, 40, 41) and is a cytokine that can induce BMMCw to preferentially express those protease transcripts and proteoglycan species (Figs. 2-4 and Table  1 ) present in serosal MC (2-4, 6-8). Thus, KL was a candidate for the fibroblast-derived activity that induced BMMC to increase their histamine and MC-CPA contents 35-100-fold during fibroblast coculture (2, 12, 33). The MC-CPA enzymatic activity in a 2-wk BMMCw/ra. was only "~0.3% of that of a mouse serosal MC, and only *5% of that of a 2-wk BMMCw/F (Table 1) . Likewise, the amount of histamine in a 2-wk BMMCw/~ was only '~3% of that of a serosal MC and only 20% of that of a BMMCw/F (Table  1) . Thus, except for heparin biosynthesis, rKL is a relatively ineffective granule-maturation factor. It is possible that the bioactivity of fibroblast-derived KL and purified yeast rKL are different because of altered posttranslational modification of the cytokine or varied presentation (e.g., soluble versus membrane bound) of the cytokine. Alternatively, a second fibroblast-derived factor such as nerve growth factor (66) might act in concert with rKL to achieve granule maturation during fibroblast cocnlture. Proliferation was at its highest level when BMMCw were cultured for 2 wk in medium containing both rlL-3 and rKL, but the rKL-induced differentiation process was suppressed. BMMCw/Ir-3.~ remained safranin-, produced predominately 35S-labeled chondroitin sulfate proteoglycans rather than 3sS-labeled heparin proteoglycans (Table 1 and Fig. 4) , did not express MMCP-4 mRNA, and contained less MMCP-6 mRNA than the starting BMMCw. This is the first demonstration of an antagonistic effect of rib3 on MC differentiation. The inability of human rlL-3 to induce human hematopoietic progenitor cells to differentiate into MC (67, 68) , and the inability to obtain mature Kirsten sarcoma-immortalized MC lines in the presence of mouse IL-3 (69) may both have been a consequence of this antagonistic effect. 
